Anti-PEBP1 center pAb ranked 17 out of 338 full length antibodies and performed better than 4 out of 8 anti-CA125 mAbs [3] in preferential binding to the serum of individual cancer patients, suggesting that PEBP1 is a marker for ovarian cancer. The gene discussed is PEBP1; the disease is ovarian carcinoma.